Literature DB >> 30827350

Pre-clinical magnetic resonance imaging of retroplacental clear space throughout gestation.

Andrew A Badachhape1, Aarav Kumar2, Ketan B Ghaghada3, Igor V Stupin4, Mayank Srivastava5, Laxman Devkota6, Zbigniew Starosolski7, Eric A Tanifum8, Verghese George9, Karin A Fox10, Chandrasekhar Yallampalli11, Ananth V Annapragada12.   

Abstract

INTRODUCTION: Visualization of the retroplacental clear space (RPCS) may provide critical insight into the development of abnormally invasive placenta (AIP). In this pre-clinical study, we characterized the appearance of the RPCS on magnetic resonance imaging (MRI) during the second half of gestation using a liposomal gadolinium contrast agent (liposomal-Gd).
MATERIALS AND METHODS: Studies were performed in fifteen pregnant C57BL/6 mice at 10, 12, 14, 16, and 18 days of gestation. MRI was performed on a 1T permanent magnet scanner. Pre-contrast and post-contrast images were acquired using T1-weighted gradient-recalled echo (T1w-GRE) and T2-weighted fast spin echo (T2w-FSE) sequences. Animals were euthanized after imaging and feto-placental units harvested for histological examination. Visualization of the RPCS was scored by a maternal-fetal radiologist and quantified by measuring the contrast-to-noise ratio (CNR) on T1w images. Feto-placental features were segmented for analysis of volumetric changes during gestation.
RESULTS: Contrast-enhanced T1w images enabled the visualization of structural changes in placental development between days 10-18 of gestation. Although the placental margin on the fetal side was clearly visible at all time points, the RPCS was partially visible at day 10 of gestation, and clearly visible by day 12. Hematoxylin and eosin (H&E) staining of the placental tissue corroborated MRI findings of structural and morphological changes in the placenta.
CONCLUSIONS: Contrast-enhanced MR imaging using liposomal-Gd enabled adequate visualization of the retroplacental clear space starting at day 12 of gestation. The agent also enabled characterization of placental structure and morphological changes through gestation.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Abnormally invasive placenta; Accreta; Liposomal-Gd blood pool contrast agent; Magnetic resonance imaging; Retroplacental space

Year:  2019        PMID: 30827350      PMCID: PMC6400291          DOI: 10.1016/j.placenta.2019.01.017

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  22 in total

1.  MRI of placenta accreta: a new imaging perspective.

Authors:  Anna Y Derman; Violeta Nikac; Shoshana Haberman; Natalie Zelenko; Oleg Opsha; Mark Flyer
Journal:  AJR Am J Roentgenol       Date:  2011-12       Impact factor: 3.959

2.  User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability.

Authors:  Paul A Yushkevich; Joseph Piven; Heather Cody Hazlett; Rachel Gimpel Smith; Sean Ho; James C Gee; Guido Gerig
Journal:  Neuroimage       Date:  2006-03-20       Impact factor: 6.556

3.  Interobserver agreement and diagnostic performance of individual MRI criteria for diagnosis of placental adhesion disorders.

Authors:  S K Goergen; E Posma; D Wrede; J Collett; J Pyman; E Alibrahim; J Keene; A Dobrotwir
Journal:  Clin Radiol       Date:  2018-07-02       Impact factor: 2.350

Review 4.  The gravid uterus: MR imaging and reporting of abnormal placentation.

Authors:  Lea Azour; Cecilia Besa; Sara Lewis; Amita Kamath; Edward R Oliver; Bachir Taouli
Journal:  Abdom Radiol (NY)       Date:  2016-12

5.  Dynamic contrast enhanced MRI of the placenta: A tool for prenatal diagnosis of placenta accreta?

Authors:  A E Millischer; B Deloison; S Silvera; Y Ville; N Boddaert; D Balvay; N Siauve; C A Cuenod; V Tsatsaris; L Sentilhes; L J Salomon
Journal:  Placenta       Date:  2017-03-10       Impact factor: 3.481

6.  Morbidly adherent placenta treatments and outcomes.

Authors:  Jennifer L Bailit; William A Grobman; Madeline Murguia Rice; Uma M Reddy; Ronald J Wapner; Michael W Varner; Kenneth J Leveno; Jay D Iams; Alan T N Tita; George Saade; Dwight J Rouse; Sean C Blackwell
Journal:  Obstet Gynecol       Date:  2015-03       Impact factor: 7.661

7.  MRI of Placenta Accreta, Placenta Increta, and Placenta Percreta: Pearls and Pitfalls.

Authors:  Aoife Kilcoyne; Anuradha S Shenoy-Bhangle; Drucilla J Roberts; Rachel Clark Sisodia; Debra A Gervais; Susanna I Lee
Journal:  AJR Am J Roentgenol       Date:  2016-10-20       Impact factor: 3.959

8.  Interobserver variability of sonography for prediction of placenta accreta.

Authors:  Zachary S Bowman; Alexandra G Eller; Anne M Kennedy; Douglas S Richards; Thomas C Winter; Paula J Woodward; Robert M Silver
Journal:  J Ultrasound Med       Date:  2014-12       Impact factor: 2.153

Review 9.  Prenatal identification of invasive placentation using ultrasound: systematic review and meta-analysis.

Authors:  F D'Antonio; C Iacovella; A Bhide
Journal:  Ultrasound Obstet Gynecol       Date:  2013-10-02       Impact factor: 7.299

10.  New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging.

Authors:  Ketan B Ghaghada; Murali Ravoori; Divya Sabapathy; James Bankson; Vikas Kundra; Ananth Annapragada
Journal:  PLoS One       Date:  2009-10-29       Impact factor: 3.240

View more
  5 in total

Review 1.  Nanotechnologies in Obstetrics and Cancer during Pregnancy: A Narrative Review.

Authors:  Serena Bertozzi; Bruna Corradetti; Luca Seriau; José Andrés Diaz Ñañez; Carla Cedolini; Arrigo Fruscalzo; Daniela Cesselli; Angelo Cagnacci; Ambrogio P Londero
Journal:  J Pers Med       Date:  2022-08-17

Review 2.  Diseases and conditions that impact maternal and fetal health and the potential for nanomedicine therapies.

Authors:  Katherine M Nelson; N'Dea Irvin-Choy; Matthew K Hoffman; Jason P Gleghorn; Emily S Day
Journal:  Adv Drug Deliv Rev       Date:  2020-09-28       Impact factor: 15.470

3.  Nanoparticle Contrast-enhanced T1-Mapping Enables Estimation of Placental Fractional Blood Volume in a Pregnant Mouse Model.

Authors:  Andrew A Badachhape; Laxman Devkota; Igor V Stupin; Poonam Sarkar; Mayank Srivastava; Eric A Tanifum; Karin A Fox; Chandrasekhar Yallampalli; Ananth V Annapragada; Ketan B Ghaghada
Journal:  Sci Rep       Date:  2019-12-10       Impact factor: 4.379

4.  Pre-clinical dose-ranging efficacy, pharmacokinetics, tissue biodistribution, and toxicity of a targeted contrast agent for MRI of amyloid deposition in Alzheimer's disease.

Authors:  Andrew A Badachhape; Peter K Working; Mayank Srivastava; Prajwal Bhandari; Igor V Stupin; Laxman Devkota; Eric A Tanifum; Ananth V Annapragada; Ketan B Ghaghada
Journal:  Sci Rep       Date:  2020-09-30       Impact factor: 4.379

Review 5.  MRI in Pregnancy and Precision Medicine: A Review from Literature.

Authors:  Gianluca Gatta; Graziella Di Grezia; Vincenzo Cuccurullo; Celestino Sardu; Francesco Iovino; Rosita Comune; Angelo Ruggiero; Marilena Chirico; Daniele La Forgia; Annarita Fanizzi; Raffaella Massafra; Maria Paola Belfiore; Giuseppe Falco; Alfonso Reginelli; Luca Brunese; Roberto Grassi; Salvatore Cappabianca; Luigi Viola
Journal:  J Pers Med       Date:  2021-12-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.